Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Rheumatol ; 28(1): 75-80, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11196547

RESUMEN

OBJECTIVE: Eosinophilic fasciitis (EF) is a scleroderma-like disease of unknown etiology characterized by skin induration, elevated immune globulins, and peripheral eosinophilia. The hallmarks of the chronic cutaneous involvement in this syndrome are inflammation and fibrosis of the fascia. To determine how the inflammatory process in EF may be regulated, we investigated the spontaneous and mitogen induced [lipopolysaccharide (LPS), phytohemagglutinin (PHA) or both LPS+PHA] syntheses of interleukins (IL)-2, 5 and 10, interferon-gamma (IFN-gamma), and leukemia inhibitory factor (LIF) cytokines by peripheral blood mononuclear cells (PBMC) from 4 patients with active EF and compared them to those of 10 healthy individuals. METHODS: We used a short term whole blood assay and culture supernatants were collected after 24 h to measure the IL-2 and IFN-gamma contents and after 48 h to evaluate IL-5, IL-10, and LIF. Supernatant cytokine concentrations were determined by ELISA. RESULTS: All 4 patients had similar patterns of cytokine secretion. Cytokine production did not differ between patients and controls under basal conditions or when LPS was added to the cultures. In contrast, under PHA or LPS+PHA stimulation, significantly higher amounts of all 5 cytokines were detected in samples from patients compared to those from controls. CONCLUSION: Overall, our data suggest that EF is characterized by an increased capacity of PBMC to produce IL-5 and IL-10, possibly leading to eosinophilia and immune globulin overexpression. In this context, the simultaneous elevations of type 1 cytokines (IL-2 and IFN-gamma) and LIF production by the same cells may be an attempt by the immune system to limit the exacerbation of a type 2 dominant response.


Asunto(s)
Eosinofilia/metabolismo , Fascitis/metabolismo , Inhibidores de Crecimiento/metabolismo , Interleucina-6 , Interleucinas/biosíntesis , Linfocinas/metabolismo , Adulto , Anciano , Células Cultivadas , Eosinofilia/patología , Fascitis/patología , Femenino , Inhibidores de Crecimiento/inmunología , Humanos , Interferón gamma/biosíntesis , Interferón gamma/inmunología , Interleucinas/inmunología , Factor Inhibidor de Leucemia , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Lipopolisacáridos , Activación de Linfocitos , Linfocinas/inmunología , Persona de Mediana Edad , Mitógenos/farmacología , Fitohemaglutininas
2.
Br J Haematol ; 110(1): 230-3, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10931005

RESUMEN

We describe the case of a teenager who developed fever, arthritis, cutaneous vasculitis and severe pancytopenia 3 weeks after the third vaccination boost with a recombinant hepatitis B vaccine. Bone marrow examination showed paucity of late myeloid elements and, subsequently, maturation arrest. Interferon-gamma (IFN-gamma) production by peripheral blood mononuclear cells from the patient was dramatically increased. An underlying immune predisposition (HLA-DR3) may have indirectly enabled the vaccine to trigger a hepatitis B virus-specific cytotoxic T-lymphocyte response. It is therefore possible that the pancytopenia was induced by a dysregulation of the CD8+ T-cell compartment via increased IFN-gamma production.


Asunto(s)
Vacunas contra Hepatitis B/efectos adversos , Pancitopenia/inducido químicamente , Vacunas Sintéticas/efectos adversos , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Interferón gamma/biosíntesis , Interleucina-10/biosíntesis , Interleucina-12/biosíntesis , Interleucina-2/biosíntesis , Pancitopenia/inmunología , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología
3.
J Clin Endocrinol Metab ; 85(2): 540-4, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10690852

RESUMEN

Granulosa cell tumors (GCT) are ovarian neoplasms that tend to recur and spread in the pelvis and the abdomen several years after the initial treatment. Anti-Mülerian hormone (AMH) is a reliable serum marker of these tumors. To enhance the availability and the sensitivity of serum AMH determination, we developed an ultrasensitive enzyme-linked immunosorbent assay. In this work we compare the results of serum AMH levels, obtained using the ultrasensitive and the traditional assays, in 31 patients with ovarian GCT followed up for up to 7 yr. The ultrasensitive enzyme-linked immunosorbent assay has a significantly higher sensitivity than the traditional one. This resulted in the detection of low serum AMH levels, which were undetectable with the traditional assay, in several cases including one patient in whom a recurrence of a GCT had developed and two patients in whom the treatment had not been completely successful. These cases highlight the importance of the availability of a highly sensitive assay allowing evaluation with high precision of the results of treatment and to detect the recurrences of GCT at an early, preclinical stage.


Asunto(s)
Ensayo de Inmunoadsorción Enzimática/métodos , Glicoproteínas , Tumor de Células de la Granulosa/sangre , Inhibidores de Crecimiento/sangre , Neoplasias Ováricas/sangre , Hormonas Testiculares/sangre , Adolescente , Adulto , Hormona Antimülleriana , Niño , Estudios de Evaluación como Asunto , Femenino , Estudios de Seguimiento , Humanos , Valores de Referencia , Sensibilidad y Especificidad
4.
Blood ; 95(2): 461-9, 2000 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-10627450

RESUMEN

On the basis of the finding of alternatively spliced mRNAs, the alpha-subunit of the receptor for GM-CSF is thought to exist in both a membrane spanning (tmGMRalpha) and a soluble form (solGMRalpha). However, only limited data has been available to support that the solGMRalpha protein product exists in vivo. We hypothesized that hematopoietic cells bearing tmGMRalpha would have the potential to also produce solGMRalpha. To test this hypothesis we examined media conditioned by candidate cells using functional, biochemical, and immunologic means. Three human leukemic cell lines that express tmGMRalpha (HL60, U937, THP1) were shown to secrete GM-CSF binding activity and a solGMRalpha-specific band by Western blot, whereas a tmGMRalpha-negative cell line (K562) did not. By the same analyses, leukapheresis products collected for autologous and allogeneic stem cell transplants and media conditioned by freshly isolated human neutrophils also contained solGMRalpha. The solGMRalpha protein in vivo displayed the same dissociation constant (Kd = 2-5 nmol) as that of recombinant solGMRalpha. A human solGMRalpha ELISA was developed that confirmed the presence of solGMRalpha in supernatant conditioned by the tmGMRalpha-positive leukemic cell lines, hematopoietic progenitor cells, and neutrophils. Furthermore, the ELISA demonstrated a steady state level of solGMRalpha in normal human plasma (36 +/- 17 pmol) and provided data suggesting that plasma solGMRalpha levels can be elevated in acute myeloid leukemias. (Blood. 2000;95:461-469)


Asunto(s)
Células Madre Hematopoyéticas/metabolismo , Neutrófilos/metabolismo , Receptores de Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Empalme Alternativo , Animales , Células CHO , Línea Celular , Clonación Molecular , Cricetinae , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Células HL-60 , Células Madre Hematopoyéticas/citología , Humanos , Células K562 , Cinética , Leucaféresis , Neutrófilos/citología , Isoformas de Proteínas/genética , ARN Mensajero/genética , Receptores de Factor Estimulante de Colonias de Granulocitos y Macrófagos/biosíntesis , Receptores de Factor Estimulante de Colonias de Granulocitos y Macrófagos/aislamiento & purificación , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Análisis de Regresión , Transfección , Células U937
5.
Clin Exp Immunol ; 115(1): 189-95, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9933441

RESUMEN

We investigated the production of IL-2, IFN-gamma, IL-10 and IL-4 by PBMC from 24 patients with SLE and 10 healthy individuals. Basal and mitogen-stimulated (lipopolysaccharide and phytohaemagglutinin (LPS + PHA)) cytokine production was determined in a whole blood assay (WBA). Supernatants were collected and assayed with specific ELISAs. Although the IL-2 and IFN-gamma contents did not differ significantly between patients and controls under both conditions, statistically significant correlations were found between each cytokine and disease activity (SLAM index) after stimulation (respectively, r = 0.501, P = 0.01 and r = 0.631, P = 0.001). PBMC IL-10 production was significantly higher for patients than controls (P = 0.05), but no correlation between IL-10 levels and the SLAM index was obtained. IL-4 production was not statistically different between SLE patients and controls. For stimulated WBAs, the IL-10/IL-2 and IL-10/IFN-gamma ratios were significantly correlated with disease severity (P = 0.02; P = 0.001, respectively). Overall, our data suggest that SLE is characterized by an elevated production of IL-10, reflecting the basal state of activation of the immune system. During exacerbation of SLE, IL-2 and IFN-gamma are synthesized in larger amounts and may cause the tissue damage observed.


Asunto(s)
Citocinas/sangre , Leucocitos Mononucleares/metabolismo , Lupus Eritematoso Sistémico/sangre , Adolescente , Adulto , Citocinas/biosíntesis , Femenino , Humanos , Interferón gamma/biosíntesis , Interleucina-10/biosíntesis , Interleucina-10/sangre , Interleucina-2/biosíntesis , Interleucina-2/sangre , Interleucina-4/biosíntesis , Interleucina-4/sangre , Masculino , Persona de Mediana Edad , Células TH1/metabolismo , Células TH1/patología , Células Th2/metabolismo , Células Th2/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA